Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
KIF6 rs20455 AG + GG pravastatin efficacy yes This analysis has been published previously (PMID:18222353) for the White subset of this study (with primary endpoint of myocardial infarction). For this study, fatal coronary event and nonfatal myocardial infarction were both included as endpoints. Authors note that DNA for the genetic analysis was collected about 1.5 yrs after the CARE trial started, so the proportion of patients with fatal coronary events was higher in the non-DNA providers. Pravastatin dose was 40 mg/day. Response is compared to patients who received placebo. Genotypes AG + GG are associated with increased response to pravastatin in people with Myocardial Infarction as compared to genotype AA. 20403483 981962878
KIF6 rs20455 AG + GG atorvastatin efficacy yes Genotypes AG + GG are associated with increased response to atorvastatin or pravastatin. 20886236 981482129
KIF6 rs9471077 AA atorvastatin efficacy yes Genotype AA is not associated with increased response to atorvastatin or pravastatin. 20886236 981482201
KIF6 rs9462535 CC atorvastatin efficacy yes Genotype CC is not associated with increased response to atorvastatin or pravastatin. 20886236 981482185
KIF6 rs9471077 AG + GG atorvastatin efficacy yes Genotypes AG + GG are associated with increased response to atorvastatin or pravastatin. 20886236 981482193
KIF6 rs9462535 AA + AC atorvastatin efficacy yes Genotypes AA + AC are associated with increased response to atorvastatin or pravastatin. 20886236 981482176
KIF6 rs20455 AA atorvastatin efficacy yes Genotype AA is not associated with increased response to atorvastatin or pravastatin. 20886236 981482167
KIF6 rs20455 GG atorvastatin efficacy no Please note that alleles have been complemented to the positive strand. Genotype GG is associated with decreased response to atorvastatin, rosuvastatin or simvastatin in people with Hypercholesterolemia as compared to genotype AA. 30304062 1449748095
KIF6 rs20455 GG atorvastatin efficacy yes Please note that alleles have been complemented to the positive strand. Genotype GG is associated with decreased response to atorvastatin or simvastatin in people with Hypercholesterolemia as compared to genotype AA. 30304062 1449748103
KIF6 rs20455 GG simvastatin efficacy no Please note that alleles have been complemented to the positive strand. A statistically significant association was seen between genotype and change in c-LDL levels, but no association was seen between genotype and change in c-HDL levels. Genotype GG is associated with decreased response to simvastatin in people with Hypercholesterolemia as compared to genotype AA. 30304062 1449748065
KIF6 rs20455 GG atorvastatin efficacy yes Please note that alleles have been complemented to the positive strand. A statistically significant association was seen between genotype and change in c-Non-HDL levels, but no significant association was seen between genotype and change in c-LDL or c-HDL levels. Genotype GG is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotype AA. 30304062 1449748074
KIF6 rs20455 GG rosuvastatin efficacy yes Please note that alleles have been complemented to the positive strand. Statistically significant association only seen between genotype and change in c-HDL Genotype GG is associated with decreased response to rosuvastatin in people with Hypercholesterolemia as compared to genotype AA. 30304062 1449748084